利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

132 条记录 (耗时 0.068 秒)

    Liquid level control device
    62.
    发明申请
    Liquid level control device 审中-公开
    液位控制装置

    公开(公告)号：US20070089505A1

    公开(公告)日：2007-04-26

    申请号：US11438097

    申请日：2006-05-17

    申请人： John Peterson

    发明人： John Peterson

    IPC分类号： G01F23/00

    CPC分类号： G05D9/02 ,  B03D1/028

    摘要： The present invention relates to a self-contained device to maintain a specific level of liquid in a pool, spa or other small body of water. More specifically, the invention relates to a self-contained mechanical device that can be detachably mounted to a spa at a desired level and maintain the level of liquid in that spa using a floatation device connected to a stopper via a lever arm. As liquid enters the device chamber through a liquid intake opening, the flotation device rises along with the level of liquid in the device. A liquid outlet opening allows the liquid in the device to exit into the spa to be maintained, thereby equalizing the level of liquid in the device and the spa. When the liquid rises to a desired level, the flotation device rises as well, pulling the lever arm and closing the stopper over the liquid intake opening.

    摘要翻译： 本发明涉及一种在池，水疗或其他小体积水中保持特定水平液体的独立装置。 更具体地，本发明涉及一种独立的机械装置，其可以可拆卸地安装到温泉所需的水平，并且通过经由杠杆臂连接到止动件的浮动装置来保持该温泉中的液体的水平。 当液体通过液体进入口进入装置室时，浮选装置随着装置中液体的液面升高。 液体出口开口允许装置中的液体离开温室以维持，从而使装置和温泉中的液体水平相等。 当液体升高到所需水平时，浮选装置也上升，拉动杠杆臂并将止动件关闭在液体进入口上。

    Projecting images onto a surface
    67.
    发明授权
    Projecting images onto a surface 有权

    公开(公告)号：US07006707B2

    公开(公告)日：2006-02-28

    申请号：US09848017

    申请日：2001-05-03

    申请人： John Peterson

    发明人： John Peterson

    IPC分类号： G06T3/00

    CPC分类号： G06T3/005 ,  G06T3/0081

    摘要： The orientation of a camera associated with a first image is determined based on a shape of a perimeter of a corrected version of the first image. The corrected version of the first image has less perspective distortion relative to a reference image than the first image. The shape of the perimeter of the corrected version of the first image is also different from the shape of the perimeter of the first image. The first image is then projected onto a surface based on the orientation of the camera.

    High affinity small molecule C5a receptor modulators
    69.
    发明授权
    High affinity small molecule C5a receptor modulators 失效
    高亲和力小分子C5a受体调节剂

    公开(公告)号：US06723743B1

    公开(公告)日：2004-04-20

    申请号：US09672071

    申请日：2000-09-28

    申请人： Andrew Thurkauf ,  Xiao-shu He ,  He Zhao ,  John Peterson ,  Xiaoyan Zhang ,  Robbin Brodbeck ,  James Krause ,  George Maynard ,  Alan Hutchison

    发明人： Andrew Thurkauf ,  Xiao-shu He ,  He Zhao ,  John Peterson ,  Xiaoyan Zhang ,  Robbin Brodbeck ,  James Krause ,  George Maynard ,  Alan Hutchison

    IPC分类号： A61K31415

    CPC分类号： C07D207/327 ,  C07C233/11 ,  C07C233/22 ,  C07C233/65 ,  C07C233/66 ,  C07C233/73 ,  C07C233/78 ,  C07C235/46 ,  C07C235/48 ,  C07C235/54 ,  C07C235/60 ,  C07C235/62 ,  C07C235/66 ,  C07C237/20 ,  C07C323/62 ,  C07C2601/08 ,  C07C2601/14 ,  C07C2602/08 ,  C07C2602/10 ,  C07C2603/18 ,  C07D213/38 ,  C07D213/82 ,  C07D215/12 ,  C07D217/04 ,  C07D217/06 ,  C07D217/14 ,  C07D217/16 ,  C07D231/12 ,  C07D233/64 ,  C07D233/68 ,  C07D235/02 ,  C07D235/14 ,  C07D235/18 ,  C07D317/58 ,  C07D333/24 ,  C07D333/28 ,  C07D333/54 ,  C07D401/06 ,  C07D401/12 ,  C07D403/12 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D417/12 ,  C07D471/04

    摘要： This invention relates to low molecular weight, non-peptidic, non-peptidomimetic, organic molecules that act as modulators of mammalian complement C5a receptors, preferably ones that act as high affinity C5a receptor ligands and also to such ligands that act as antagonists or inverse agonists of complement C5a receptors, preferably human C5a receptors, Preferred compounds of the invention possess one or more, and preferably two or more, three or more, four or more, or all of the following properties in that they are; 1) multi-aryl in structure (having a plurality of un-fused or fused aryl groups), 2) heteroaryl in structure, 3) orally available in vivo (such that a sub-lethal or preferably a pharmaceutically acceptable oral dose can provide a detectable in vitro effect such as a reduction of C5a-induced neutropenia), 4) comprised of fewer than four, preferably fewer than three, or fewer than two, or no amide bonds, and 5) capable of inhibiting leukocyte chemotaxis at nanomolar concentrations and preferably at sub-nanomolar concentrations. Specifically exemplified representative compounds include, but are not limited to optionally substituted arylimidazoles, optionally substituted arylpyridyls, optionally substituted aryl-substituted cycloalkylimidazoles, optionally substituted arylpyrazoles, optionally substituted benzimidazoles, optionally substituted aryl-substituted tetrahydroisoquinolines, and optionally substituted biaryl carboxamides. This invention also relates to pharmaceutical compositions comprising such compounds. It further relates to the use of such compounds in treating a variety of inflammatory and immune system disorders. Additionally, this invention relates to the use such compounds as probes for the localization of C5a receptors.

    摘要翻译： 本发明涉及作为哺乳动物补体C5a受体调节剂的低分子量，非肽，非拟肽，有机分子，优选用作高亲和力C5a受体配体的调节剂，还涉及作为拮抗剂或反向激动剂的这些配体 的补体C5a受体，优选人C5a受体。本发明的优选化合物具有一个或多个，优选两个或更多个，三个或更多个，四个或更多个或全部以下性质： 1）结构上的多芳基（具有多个未稠合或稠合芳基），2）结构上的杂芳基，3）在体内可口服（使得亚致死或优选药学上可接受的口服剂量可提供 可检测的体外效应，例如C5a诱导的中性粒细胞减少的减少），4）由少于4个，优选少于3个，或少于2个或不存在的酰胺键组成，以及5）能够以纳摩尔浓度抑制白细胞趋化性， 优选亚纳摩尔浓度。 具体示例的代表性化合物包括但不限于任选取代的芳基咪唑，任选取代的芳基吡啶基，任选取代的芳基取代的环烷基咪唑，任选取代的芳基吡唑，任选取代的苯并咪唑，任选取代的芳基取代的四氢异喹啉和任选取代的双芳基甲酰胺。 本发明还涉及包含这些化合物的药物组合物。 它还涉及这些化合物在治疗各种炎性和免疫系统疾病中的应用。 此外，本发明涉及使用这些化合物作为C5a受体定位的探针。

    Key fob
    70.
    外观设计
    Key fob 失效
    钥匙扣

    公开(公告)号：USD461047S1

    公开(公告)日：2002-08-06

    申请号：US29136125

    申请日：2001-01-26

    申请人： John Peterson

    设计人： John Peterson